Results 31 to 40 of about 65,257 (310)

Guillain-Barre syndrome in 220 patients with COVID-19

The Egyptian Journal of Neurology Psychiatry and Neurosurgery, 2021
This review summarises and discusses recent findings concerning the pathophysiology, clinical presentation, diagnosis, treatment, and outcome of SARS-CoV-2-associated Guillain-Barre syndrome (SC2-GBS).
J. Finsterer, F. Scorza
semanticscholar   +1 more source

Guillain-Barre Syndrome, Clinical Spectrum and Electrophysiological Sub Types: A Local Experience

Journal of Shalamar Medical & Dental College, 2023
Background: Guillain-Barre syndrome is uncommon neurological disease that occurs in acute phase as generalized polyradiculo-neuropathy. It has multiple variants some of them being uncommon and rarely encountered.
Faryal Shamim, Safia bano safia, Masooma Waqar, Ahsan Numan   +3 more
doaj   +1 more source

Second intravenous immunoglobulin dose in patients with Guillain-Barre syndrome with poor prognosis (SID-GBS):a double-blind, randomised, placebo-controlled trial [PDF]

, 2021
Background Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barre syndrome.
, Arends, Samuel, Badrising, Umesh A., Bienfait, Henriette M. E., Blom, Roderik J., Breukelman, Albert-Jan J., Budde, Ilona Kleine, de Rijk, Maarten C., Dieks, Rita J. G., Doets, Alexandra Y., Drenthen, Judith, Eftimov, Filip, Faber, Catharina G., Garssen, Marcel P. J., Gijsbers, Cees J., Gilhuis, H. Job, Groen, Rutger J., Huizinga, Ruth, Jacobs, Bart C., Jellema, Korne, Kleyweg, Ruud P., Kuitwaard, Krista, Kuks, Jan B. M., Leonhard, Sonja E., Lingsma, Hester F., Linssen, Wim H. J. P., Lovenich, Harry, Merkies, Ingemar S. J., Samijn, Johnny P. A., Stevens, Martijn, Steyerberg, Ewout W., van den Berg, Bianca, van der Graaff, Maaike M., van der Kooi, Anneke J., van der Kooi, Elly L., van der Meulen, Marjon F. G., van der Meulen, Willem D. M., van der Pol, W. Ludo, van der Ree, Taco C., van Dijk, Gert W., van Engelen, Baziel G. M., van Koningsveld, Rinske, van Oosten, Bob W., Verboon, Christine, Vermeij, Frederique H., Verschuuren, Jan J. G. M., Visser, Leo H., Walgaard, Christa, Wirtz, Paul W., Wohlgemuth, Marielle, Zwetsloot, Casper P.   +50 more
core   +1 more source

Guillain–Barré Syndrome Variant Occurring after SARS‐CoV‐2 Vaccination

Annals of Neurology, 2021
Although SARS‐CoV‐2 vaccines are very safe, we report 4 cases of the bifacial weakness with paresthesias variant of Guillain–Barré syndrome (GBS) occurring within 3 weeks of vaccination with the Oxford–AstraZeneca SARS‐CoV‐2 vaccine.
C. Allen, Shelby Ramsamy, A. Tarr, P. Tighe, W. Irving, R. Tanasescu, Jonathan Evans   +6 more
semanticscholar   +1 more source

New technologies in rehabilitation: plantar imitator of bearing load for patients with Guillain-Barre syndrome

Анналы клинической и экспериментальной неврологии, 2017
Guillain-Barre syndrome often requires administration in intensivecare unit but is associated with good prognosis. That usuallymeans partial or full regress of motor impairment. However,we found that many reconvalescents after Guillain-Barre syndromewere
A. A. Khoroshun, M. A. Piradov, L. A. Chernikova   +2 more
doaj   +1 more source

Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions

Journal of Neurology Neurosurgery & Psychiatry, 2020
Objective Single cases and small series of Guillain-Barré syndrome (GBS) have been reported during the SARS-CoV-2 outbreak worldwide. We evaluated incidence and clinical features of GBS in a cohort of patients from two regions of northern Italy with the ...
M. Filosto, S. Cotti Piccinelli, S. Gazzina, C. Foresti, B. Frigeni, M. C. Servalli, M. Sessa, G. Cosentino, E. Marchioni, S. Ravaglia, C. Briani, F. Castellani, G. Zara, F. Bianchi, U. Del Carro, R. Fazio, M. Filippi, E. Magni, G. Natalini, F. Palmerini, A. Perotti, A. Bellomo, M. Osio, G. Scopelliti, M. Carpo, A. Rasera, G. Squintani, P. Doneddu, V. Bertasi, Maria Sofia Cotelli, L. Bertolasi, G. Fabrizi, S. Ferrari, F. Ranieri, F. Caprioli, E. Grappa, L. Broglio, G. D. De Maria, Ugo Leggio, L. Poli, F. Rasulo, N. Latronico, E. Nobile‐Orazio, A. Padovani, A. Uncini   +44 more
semanticscholar   +1 more source

Guillain-Barre syndrome in pregnancy: A rare disease with challenging management

Ibom Medical Journal, 2023
Background: Guillain-Barre syndrome is a rare autoimmune disorder in pregnancy, characterised by ascending polyneuropathy. Diagnosis is mainly clinical and treatment is mainly supportive.
Uwagboe UC, Isikhuemen ME
doaj   +1 more source

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni Predominates

International Journal of Molecular Sciences, 2022
Guillain–Barré syndrome (GBS) is a rare immune-mediated acute polyradiculo-neuropathy that typically develops after a previous gastrointestinal or respiratory infection. This narrative overview aims to summarise and discuss current knowledge and previous
J. Finsterer
semanticscholar   +1 more source

Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination [PDF]

, 2013
Influenza vaccination has been implicated in Guillain Barré Syndrome (GBS) although the evidence for this link is controversial. A case–control study was conducted between October 2010 and May 2011 in seven Italian Regions to explore the relation between
Beghi, E, Benedetti, M D, Chiò, A, D'Alessandro, R, Filippini, G, Galeotti, F, Granieri, E, Itang, study group., Logroscino, G, Massari, M, Pugliatti, M, Raschetti, R, Santuccio, C   +12 more
core   +1 more source

Guillain-Barré syndrome after COVID-19 vaccination

BMJ Case Reports, 2021
We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca).
Norma McKean, Charmaine Chircop
semanticscholar   +1 more source